173 related articles for article (PubMed ID: 29631075)
1. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.
Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G
J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075
[TBL] [Abstract][Full Text] [Related]
2. Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma.
Cheng J; Zheng G; Jin H; Gao X
Comb Chem High Throughput Screen; 2017; 20(2):133-139. PubMed ID: 28000565
[TBL] [Abstract][Full Text] [Related]
3. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging.
Xu J; Chen Y; Zhang R; He J; Song Y; Wang J; Wang H; Wang L; Zhan Q; Abliz Z
Sci Rep; 2016 Oct; 6():35010. PubMed ID: 27725730
[TBL] [Abstract][Full Text] [Related]
4. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
[TBL] [Abstract][Full Text] [Related]
5. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform.
Zhang H; Wang L; Hou Z; Ma H; Mamtimin B; Hasim A; Sheyhidin I
Biochem Biophys Res Commun; 2017 Sep; 491(1):119-125. PubMed ID: 28711496
[TBL] [Abstract][Full Text] [Related]
7. Development of a metabolic pathway-based pseudo-targeted metabolomics method using liquid chromatography coupled with mass spectrometry.
Xu J; Li J; Zhang R; He J; Chen Y; Bi N; Song Y; Wang L; Zhan Q; Abliz Z
Talanta; 2019 Jan; 192():160-168. PubMed ID: 30348373
[TBL] [Abstract][Full Text] [Related]
8. Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma.
Jin H; Qiao F; Chen L; Lu C; Xu L; Gao X
J Proteome Res; 2014 Sep; 13(9):4091-103. PubMed ID: 25162382
[TBL] [Abstract][Full Text] [Related]
9. Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma.
Gao M; Wu J; Zhou S; Chen Y; Wang M; He W; Jiang L; Shu Y; Wang X
Microbiol Spectr; 2024 May; 12(5):e0401223. PubMed ID: 38497715
[TBL] [Abstract][Full Text] [Related]
10. LC-MS-based serum metabolomic analysis reveals dysregulation of phosphatidylcholines in esophageal squamous cell carcinoma.
Mir SA; Rajagopalan P; Jain AP; Khan AA; Datta KK; Mohan SV; Lateef SS; Sahasrabuddhe N; Somani BL; Keshava Prasad TS; Chatterjee A; Veerendra Kumar KV; VijayaKumar M; Kumar RV; Gundimeda S; Pandey A; Gowda H
J Proteomics; 2015 Sep; 127(Pt A):96-102. PubMed ID: 25982385
[TBL] [Abstract][Full Text] [Related]
11. Untargeted metabolomics analysis of esophageal squamous cell cancer progression.
Yang T; Hui R; Nouws J; Sauler M; Zeng T; Wu Q
J Transl Med; 2022 Mar; 20(1):127. PubMed ID: 35287685
[TBL] [Abstract][Full Text] [Related]
12. Plasma free amino acid profiling of esophageal cancer using high-performance liquid chromatography spectroscopy.
Ma H; Hasim A; Mamtimin B; Kong B; Zhang HP; Sheyhidin I
World J Gastroenterol; 2014 Jul; 20(26):8653-9. PubMed ID: 25024622
[TBL] [Abstract][Full Text] [Related]
13. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
14. SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.
Kashyap MK; Harsha HC; Renuse S; Pawar H; Sahasrabuddhe NA; Kim MS; Marimuthu A; Keerthikumar S; Muthusamy B; Kandasamy K; Subbannayya Y; Prasad TS; Mahmood R; Chaerkady R; Meltzer SJ; Kumar RV; Rustgi AK; Pandey A
Cancer Biol Ther; 2010 Oct; 10(8):796-810. PubMed ID: 20686364
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Guo YL; Shan BE; Guo W; Dong ZM; Zhou Z; Shen SP; Guo X; Liang J; Kuang G
J Biomed Sci; 2017 Jan; 24(1):6. PubMed ID: 28077137
[TBL] [Abstract][Full Text] [Related]
16. High expression of SGTA in esophageal squamous cell carcinoma correlates with proliferation and poor prognosis.
Yang X; Cheng L; Li M; Shi H; Ren H; Ding Z; Liu F; Wang Y; Cheng C
J Cell Biochem; 2014 Jan; 115(1):141-50. PubMed ID: 23939810
[TBL] [Abstract][Full Text] [Related]
17. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
Liu L; Yang Z; Ni W; Xuan Y
Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
[TBL] [Abstract][Full Text] [Related]
18. ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma.
Otsuka R; Akutsu Y; Sakata H; Hanari N; Murakami K; Kano M; Toyozumi T; Takahashi M; Matsumoto Y; Sekino N; Yokoyama M; Okada K; Shiraishi T; Komatsu A; Iida K; Matsubara H
Oncology; 2018; 94(3):142-148. PubMed ID: 29216641
[TBL] [Abstract][Full Text] [Related]
19. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
[TBL] [Abstract][Full Text] [Related]
20. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
